Glenmark concludes PMS study on Favipiravir in COVID patients ruchika17 Sep 2021 7:33 AM GMTMumbai: Drugmaker, Glenmark Pharmaceuticals, has recently announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipi...
Glenmark gets CDSCO panel nod to market Remogliflozin, Vildagliptin, Metformin FDC drug Medical Dialogues Team12 Sep 2021 5:30 AM GMTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark Pha...
COVID treatment: Glenmark gets CDSCO panel okay for phase 3 trial of Nitric Oxide nasal spray Medical Dialogues Team24 Aug 2021 11:39 AM GMTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO), h...
Glenmark profit after tax up 21 percent at Rs 306 crore in Q1 ruchika15 Aug 2021 3:30 AM GMTNew Delhi: Glenmark Pharmaceuticals on Friday said its consolidated profit after tax (PAT) increased by 21 per cent to Rs 306 crore for the first quart...
Fitch affirms Glenmark at BB on IPO of API business ruchika10 Aug 2021 7:45 AM GMTSingapore: Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (...
Glenmark, SaNOtize collaborate to commercialize Nitric Oxide Nasal Spray for COVID-19 in Asian markets ruchika2 Aug 2021 9:24 AM GMTNitric Oxide Nasal Spray is one of the few novel therapeutic treatments, outside of expensive monoclonal antibodies, that is proven to reduce...
Glenmark arm to invest Rs 600 crore to double capacity in 4 years ruchika23 July 2021 3:30 AM GMTMumbai: IPO-bound bulk drug manufacturer Glenmark Life Sciences is on track to more than double its capacity over the next four years at a cumulative i...
Glenmark subsidiary IPO to open next week ruchika21 July 2021 5:30 AM GMTNew Delhi: Glenmark Pharmaceuticals on Tuesday said the initial public offering of its subsidiary Glenmark Life Sciences will open on July 27.On July 1...
Glenmark to conduct phase 3 trials of nasal spray it claims to be effective in COVID treatment ruchika10 July 2021 6:45 AM GMTNew Delhi: Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19...
Fitch affirms Glenmark issuer default rating at BB with stable outlook ruchika6 July 2021 7:00 AM GMTSingapore: Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook.It said Glenmark's geo...
Glenmark bags USFDA nod for Nintedanib Capsules ruchika25 Jun 2021 5:25 AM GMTMumbai: Drug maker, Glenmark Pharmaceuticals Ltd, today announced that the company has received tentative approval from the United States Food & D...
Glenmark bags USFDA nod for Arformoterol Tartrate Inhalation Solution ruchika23 Jun 2021 7:19 AM GMTMumbai: Drugmaker, Glenmark Pharmaceuticals Ltd, today announced that the company has received final approval from the United States Food & Drug Ad...
